Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 20, 2009

Merck Eprova AG v. Brookstone Pharmaceuticals, LLC

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 31, 2013

    Merck & Cie Wins $11.6M Over Acella's Supplements Marketing

    A New York federal judge on Thursday ordered Acella Pharmaceuticals LLC to pay $11.6 million in damages to drugmaker Merck & Cie Schaffhausen, finding that Acella falsely marketed its folate supplements as substitutes for Merck's brand-name Metafolin, in violation of the Lanham Act.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login